. . . . . . . "[A phase I dose-escalating trial was recently performed in patients with advanced knee OA to examine the safety and activity of chondrocytes modified to produce the transforming growth factor ?1 via intra-articular injection, showing a dose-dependent trend toward efficacy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2017-02-19"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2017-10-17T13:16:39+02:00"^^ . . . . . . . . . . . "v5.0.0.0" . "v5.0.0" .